• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病相关构音障碍的呼吸/发声功能障碍的行为管理:系统评价。

Behavioral Management of Respiratory/Phonatory Dysfunction for Dysarthria Associated With Neurodegenerative Disease: A Systematic Review.

机构信息

University of Canterbury/Otago, Christchurch, New Zealand.

New Zealand Brain Research Institute, Christchurch.

出版信息

Am J Speech Lang Pathol. 2024 Mar 7;33(2):1069-1097. doi: 10.1044/2023_AJSLP-23-00274. Epub 2024 Jan 17.

DOI:10.1044/2023_AJSLP-23-00274
PMID:38232176
Abstract

PURPOSE

This systematic review represents an update to previous reviews of the literature addressing behavioral management of respiratory/phonatory dysfunction in individuals with dysarthria due to neurodegenerative disease.

METHOD

Multiple electronic database searches and hand searches of prominent speech-language pathology journals were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards.

RESULTS

The search yielded 1,525 articles, from which 88 met inclusion criteria and were reviewed by two blinded co-investigators. A large range of therapeutic approaches have been added to the evidence base since the last review, including expiratory muscle strength training, singing, and computer- and device-driven programs, as well as a variety of treatment modalities, including teletherapy. Evidence for treatment in several different population groups-including cerebellar ataxia, myotonic dystrophy, autosomal recessive spastic ataxia of Charlevoix-Saguenay, Huntington's disease, multiple system atrophy, and Lewy body dementia-were added to the current review. Synthesis of evidence quality provided strong evidence in support of only one behavioral intervention: Lee Silverman Voice Treatment Program (LSVT LOUD) in people with Parkinson's disease. No other treatment approach or population included in this review demonstrated more than limited evidence, reflecting that these approaches/populations require urgent further examination.

CONCLUSION

Suggestions about where future research efforts could be significantly strengthened and how clinicians can apply research findings to their practice are provided.

SUPPLEMENTAL MATERIAL

https://doi.org/10.23641/asha.24964473.

摘要

目的

这篇系统综述是对之前针对神经退行性疾病导致构音障碍者呼吸/发声功能障碍的行为管理的文献综述的更新。

方法

根据系统评价和荟萃分析的首选报告项目标准,对多个电子数据库和著名言语病理学杂志进行了手工检索。

结果

搜索结果产生了 1525 篇文章,其中 88 篇符合纳入标准,并由两名盲法共同研究者进行了审查。自上次综述以来,证据基础中增加了大量治疗方法,包括呼气肌力量训练、唱歌和计算机及设备驱动程序,以及各种治疗方式,包括远程治疗。当前综述增加了几个不同人群的治疗证据,包括小脑共济失调、肌强直性营养不良、常染色体隐性痉挛性共济失调、亨廷顿病、多系统萎缩和路易体痴呆。对证据质量的综合分析仅为一种行为干预提供了强有力的证据支持:帕金森病患者的 Lee Silverman 语音治疗计划(LSVT LOUD)。本综述中包含的其他治疗方法或人群没有超过有限的证据,这反映出这些方法/人群需要进一步紧急检查。

结论

提供了有关未来研究工作可以在哪里得到显著加强以及临床医生如何将研究结果应用于实践的建议。

补充材料

https://doi.org/10.23641/asha.24964473。

相似文献

1
Behavioral Management of Respiratory/Phonatory Dysfunction for Dysarthria Associated With Neurodegenerative Disease: A Systematic Review.神经退行性疾病相关构音障碍的呼吸/发声功能障碍的行为管理:系统评价。
Am J Speech Lang Pathol. 2024 Mar 7;33(2):1069-1097. doi: 10.1044/2023_AJSLP-23-00274. Epub 2024 Jan 17.
2
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.李·西尔弗曼语音治疗与英国国民保健制度(NHS)言语和语言治疗对照治疗帕金森病(PD COMM)患者构音障碍的实用性、基于英国、多中心、三臂、平行组、非盲、随机对照试验。
BMJ. 2024 Jul 10;386:e078341. doi: 10.1136/bmj-2023-078341.
3
[The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)].[使用LSVT(李·西尔弗曼嗓音治疗法)对帕金森病构音障碍进行康复治疗的进展]
Otolaryngol Pol. 2007;61(5):713-8. doi: 10.1016/s0030-6657(07)70511-5.
4
Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.李·西尔弗曼语音治疗帕金森病患者构音障碍:系统评价和荟萃分析。
Eur J Neurol. 2020 Oct;27(10):1957-1970. doi: 10.1111/ene.14399. Epub 2020 Aug 12.
5
Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.强化嗓音治疗(李·西尔弗曼嗓音治疗法[LSVT])对共济失调性构音障碍的影响:一项病例研究。
Am J Speech Lang Pathol. 2003 Nov;12(4):387-99. doi: 10.1044/1058-0360(2003/085).
6
A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.帕金森病构音障碍的言语和语言治疗技术比较
Cochrane Database Syst Rev. 2001(2):CD002814. doi: 10.1002/14651858.CD002814.
7
Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.帕金森病言语问题的言语和语言治疗技术比较
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD002814. doi: 10.1002/14651858.CD002814.pub2.
8
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.一项多中心、随机对照试验,旨在比较李·西尔弗曼嗓音治疗与标准国民保健制度语音和语言治疗与对照组在帕金森病中的临床和成本效益:一项随机对照试验的研究方案。
Trials. 2020 May 27;21(1):436. doi: 10.1186/s13063-020-04354-7.
9
Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.李·西尔弗曼嗓音治疗扩展版对帕金森病患者嗓音和言语的影响。
Am J Speech Lang Pathol. 2007 May;16(2):95-107. doi: 10.1044/1058-0360(2007/014).
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
An Imitation-Based Treatment for Ataxic Dysarthria: A Retrospective Multiple Single-Case Study.一种基于模仿的共济失调性构音障碍治疗方法:一项回顾性多单病例研究。
Biomedicines. 2025 Jul 8;13(7):1666. doi: 10.3390/biomedicines13071666.
2
Prevalence and Treatment of Dysphonia in Parkinson's Disease: A Cross-Sectional National Database Study.帕金森病中发声障碍的患病率及治疗:一项全国性横断面数据库研究
Laryngoscope Investig Otolaryngol. 2025 May 14;10(3):e70149. doi: 10.1002/lio2.70149. eCollection 2025 Jun.
3
A Podcast on the Rhythms of Healing: Patient and Physician Insights on Art, Music, Dance Therapy and Creativity in Parkinson's Disease.
关于治愈节奏的播客:帕金森病患者与医生对艺术、音乐、舞蹈疗法及创造力的见解
Neurol Ther. 2025 Apr;14(2):429-436. doi: 10.1007/s40120-024-00688-5. Epub 2025 Jan 18.
4
Linking the impact of aspiration to host variables using the BOLUS framework: support from a rapid review.使用BOLUS框架将误吸的影响与宿主变量联系起来:快速综述的支持
Front Rehabil Sci. 2024 Jul 12;5:1412635. doi: 10.3389/fresc.2024.1412635. eCollection 2024.
5
Narrative analysis in individuals with Parkinson's disease following intensive voice treatment: secondary outcome variables from a randomized controlled trial.帕金森病患者强化嗓音治疗后的叙事分析:一项随机对照试验的次要结局变量
Front Hum Neurosci. 2024 May 22;18:1394948. doi: 10.3389/fnhum.2024.1394948. eCollection 2024.